Early Access — free while we kick the tires
EdgarHawk

Kiper Christopher S

Director

Director 10% Owner
1 filing analyzed · 1 company · Latest 2024-10-07

Companies

Company Buys Sells Direction
LIFECORE BIOMEDICAL, INC. \DE\ LFCR 2 0 Net buying

Activity

October 2024
Buy
1,463,414 shares
$5,999,997
Significance 7/10

Director Kiper buys 1,463,414 shares for $5,999,997.40 at $4.10; current price $5.09, down 40.5% from 52-week high.

Kiper Christopher S, a Director, executed 2 separate purchases totaling 1,463,414 shares for $5,999,997.40 at a blended average price of $4.10 per share. This acquisition is notable given the company's financial stress: LifeCore reported net income of -$16,230,000.00 in its latest quarter while generating $24,705,000.00 in revenue, and the stock is currently trading at $5.09, down 40.5% from its 52-week high of $8.55. The director's post-transaction holding of 319,286 shares contrasts with a pre-transaction position of -1,144,128 shares, indicating this purchase resolves a previous short or other negative position. The transaction represents a material capital commitment at a point of depressed valuation relative to recent historical range, though the company maintains positive annual revenue growth of 24.2% year-over-year.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access